- Home
- About
- Find staff
- Marcus Lind
Marcus Lind
About Marcus Lind
Marcus Lind presented his thesis in year 2009 at the University of Gothenburg focusing on evaluating effects of modern insulin analogues and HbA1c as a risk factor for diabetic complications. During his post-doc period he performed work at the Mid-America Heart Institute, Missouri University, US. Besides his research he has worked clinical as chief physician of Diabetology at the NU (NÄL and Uddevalla)-Hospital Group. He became Associate Professor of Diabetology year 2014 at the University of Gothenburg. He has performed essential research both in the epidemiologic field and clinical randomized trials which have been presented in New England Journal of Medicine, Lancet, JAMA and British Medical Journal. He has been in charge of over 40 studies.
Honors and Awards:
The Erik K Fernströms award 2019 which is awarded 1 researcher each year at each university in Sweden. Awarded by Lund University.
The Jubilee Prize at the 200 year anniversary of the Gothenburg Society for Physicians which was awarded to two physicians at the University of Gothenburg among all disciplines.
The Jubilee Prize year 2017 awarded one physician in Sweden among all disciplines. Awarded by the Society of Physicians in Sweden.
Prize from Dr P Håkanssons Foundation for studies of diet in diabetes year 2017.
National prize 2012 from Swedish Society for Diabetology (SFD) for best diabetic publication in Sweden in 2011 regarding Heart Failure in Persons with Type 1 Diabetes. (Lind. M., Lancet, June, 2011)
Prize as the “Diabetologist of the year” in Sweden in 2009 for research of metabolic memory and diabetic complications in the DCCT study.
Prize for good scientific methodology and presentation at the "National meeting for physicians in Sweden in 2006”.
Text books
Main editor for the text book “Medicinska Sjukdomar”. A text book in internal medicine of approximately 800 pages comprising the different fields in internal medicine. Author of the diabetes and endocrinology chapters. Released by “Studentlitteratur” year 2020.
Author in the text book “Diabetes” released by “Studentlitteratur” year 2020, comprising approximately 500 pages.
Main research
Dr Marcus Lind focuses on clinical diabetes research. His research performs epidemiologic studies and clinical trials in the field of diabetes.
The research is focused on improving prognosis and evaluating suitable treatments to reduce the risk of complications for type 1 and 2 diabetes.
Dr Lind performs research evaluating which risk factors are associated with a lower mortality and risks of complications on the retina, kidneys, nerves and cardiovascular system. His group also focuses on understanding what persons are at risk for acute complications from diabetes. These studies are often of epidemiologic origin. As a complement the research group perform prospective studies and clinical trials to try to improve treatments in type 1 and type 2 diabetes. Essential fields are:
- Screening studies to earlier detect complications
- Diabetes Technology – e.g. of continuous glucose monitoring and insulin pumps
- Psychologic interventions
- Diet interventions
- Glucose-lowering drugs in persons with type 1 and type 2 diabetes
- Immunologic studies to preserve endogenous insulin production
Group members
Dr Lind is responsible for two diabetes clinical trial units. One at Sahlgrenska University Hospital/Östra, Gothenburg and one at the NU-Hospital Group, Uddevalla, Sweden.
PhD Students:
Earlier PhD students who have performed their PhD dissertations in the research group are:
- Viktorija Anägnen Matuleviciene, Chief Physician at the Emergency Department of the Karolinska University Hospital, Stockholm, Sweden
- Daniel Vestberg, Specialist Internal Medicine, NU-Hospital Group, Trollhättan and Uddevalla, Sweden
Current PhD students are:
- Elsa Ahlén
- Shilan Ahmadi
- Sara Hallström
- Sofia Sterner Isaksson
- Arndís Finna Ólafsdóttir
- Mauro Tancredi
Research Nurses and study coordinators
- Marie Ekström, Sahlgrenska University Hospital/Östra and the NU-Hospital Group
- Anna Folino, Sahlgrenska University Hospital/Östra and Sahlgrenska University Hospital/Mölndal
Research assistants:
- Marianne Johansson, NU-Hospital Group
- Daniel Pylov, University of Gothenburg
Medical Doctors assisting in clinical trials:
- Lennart Kareld, senior consultant in internal medicine focusing on cardiology
- Thomas Eriksson, senior consultant in internal medicine focusing on gastroenterology
The group has created a network of collaborations with data managers, monitors, logistics for laboratory handling, drug logistics and experienced statisticians for performing multicentre randomized clinical trials and epidemiologic studies. These are crucial close collaborators to the group for performing the research work.
Key Publications
- Hallström S, Wijkman MO, Ludvigsson J, Ekman P, Pfeffer MA, Wedel H, Rosengren A, Lind M. Risk factors, mortality trends and cardiovasuclar diseases in people with Type 1 diabetes and controls: A Swedish observational cohort study. Lancet Reg Health Eur. 2022 Jul 22;21:100469. doi: 10.1016/j.lanepe.2022.100469. PMID: 35898332; PMCID: PMC9309414.
- Lind M, Imberg H, Coleman RL, Nerman O, Holman RR. Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88. Diabetes Care. 2021 Jul 7:dc202439. doi: 10.2337/dc20-2439. Epub ahead of print. PMID: 34244332.
- Lind M, Ólafsdóttir AF, Hirsch IB, Bolinder J, Dahlqvist S, Pivodic A, Hellman J, Wijkman M, Schwarcz E, Albrektsson H, Heise T, Polonsky W. Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI. Diabetes Care. 2021 Jan;44(1):141-149.
- Lind M., Pivodic A., Svensson A-M., Ólafsdóttir AF., Wedel H., Ludvigsson J., HbA1c as a risk factor for retinopathy and nephropathy in persons with type 1 diabetes: Swedish Cohort study. BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4894
- Vilsbøll T, Ekholm E, Johnsson E, Dronamraju N, Jabbour S, Lind M. Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial. Diabetes Care. 2019 Aug;42(8):1464-1472. doi: 10.2337/dc18-1988.
- Dahlqvist S., Rosengren A., Gudbjornsdottir S., Pivodic A., Kosiborod M,Svensson A-M, Lind M. Risk of atrial fibrillation in persons with type 1 diabetes compared to matched controls from the general population - a prospective case-control study. Lancet Diabetes Endocrinol. 2017 Oct;5(10):799-807. doi: 10.1016/S2213-8587(17)30262-0
- Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Ólafsdóttir AF, Frid A, Wedel H, Ahlén E, Nyström T, Hellman J. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA. 24;317(4):379-387. (2017)
- Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjörnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M. Excess Mortality among Persons with Type 2 Diabetes. N Engl J Med. 373(18):1720-1732. (2015)
- Lind M, Svensson AM, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Wedel H, Dahlqvist S, Clements M, Rosengren A. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 371(21):1972-82. (2014)
- Lind M, Hirsch IB, Tuomilehto J, Dahlqvist S, Ahrén B, Torffvit O, Attvall S, Ekelund M, Filipsson K, Tengmark BO, Sjöberg S, Pehrsson NG. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial). BMJ. 351:h5364. (2015)
- Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson AM, Rosengren A. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet. 378(9786):140-6. (2011)
- Matuleviciene V, Joseph JI, Andelin M, Hirsch IB, Attvall S, Pivodic A, Dahlqvist S, Klonoff D, Haraldsson B, Lind M. A Clinical Trial of the Accuracy and Treatment Experience of the Dexcom G4 Sensor (Dexcom G4 System) and Enlite Sensor (Guardian REAL-Time System) Tested Simultaneously in Ambulatory Patients with Type 1 Diabetes. Diabetes Technol Ther. 16(11):759-67. (2014)
- Lind M, Pivodic A, Cea-Soriano L, Nerman O, Pehrsson NG, Garcia-Rodriguez LA. Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK. Diabetologia. 57(8):1586-94. (2014)
- Rosengren A, Svensson A-M, Kosiborod M, Pivodic A, Clements C, Gudbjörnsdottir S, Lind M. Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control study. Lancet Diabetes Endocrinol. 3(11):876-85. (2015)
- Ólafsdóttir A.F., Attvall S., Sandgren U., Dahlqvist S., Pivodic A., Stanko S., Theodorsson E., Lind M. A clinical trial of the accuracy and treatment experience of the flash glucose monitor Free Style Libre in persons with type 1 diabetes. Accepted in Diabetes Diabetes Technol Ther. 19(3):164-172. (2017)
- Olsson M, Schnecke V, Cabrera C, Skrtic S, Lind M. Contemporary Risk Estimates of Three HbA1c Variables for Myocardial Infarction in 101,799 Patients Following Diagnosis of Type 2 Diabetes. Diabetes Care. 38(8):1481-6. (2015)
Pågående aktiviteter hösten 2023
Tre studier kommer presenteras på EASD, Europeiska kongressen för diabetes i början av oktober.
Doktorand Sara Hallström disputerar.
Kliniska behandlingsstudier om kolhydratreducerad kost och CGM-behandling med distanssupport avslutas och sammanställs.
Rekrytering av patienter i studie om diabetesutbildad psykolog avslutas REDDIE-projektet initieras. En EU-studie där kardiovaskulära effekter av diabetesbehandlingar studeras.
-
Design and methods of a multicenter randomized clinical trial of effects of diabetes-educated psychologist on glucose management and diabetes
distress
Johanna Zeijlemaker, Therese Anderbro, Sofia Sterner Isaksson, Marcus Lind
Frontiers in Clinical Diabetes and Healthcare - 2025 -
Prevention of glucocorticoid-induced impairment of bone metabolism - a randomized, placebo-controlled, single centre proof-of-concept clinical
trial
Giulia Gregori, Lisa Johansson, Lena Silberberg, Henrik Imberg, Per Magnusson, Marcus Lind, Mattias Lorentzon
JBMR Plus - 2025 -
Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized
Trial
Daniel Pylov, W. Polonsky, Henrik Imberg, H. Holmer, J. Hellman, M. Wijkman, J. Bolinder, T. Heisse, S. Dahlqvist, T. Nystrom, E. Schwarz, I. Hirsch, Marcus Lind
Journal of Diabetes Science and Technology - 2025 -
Risk Factors for Retinopathy in Young Adults With Type 1
Diabetes
Shilan Seyed Ahmadi, Johnny Ludvigsson, Henrik Imberg, Thomas Nystroem, Marcus Lind
JAMA OPHTHALMOLOGY - 2025 -
Evaluating the Adequacy of Coefficient of Variation and Standard Deviation as Metrics of Glucose Variability in Type 1 Diabetes Based on Data from the GOLD and SILVER
Trials
Pavel Jamal Fatulla, Henrik Imberg, Sofia Sterner Isaksson, Irl B. Hirsch, Johan Martensson, Hanna Liljeback, Tim Heise, Marcus Lind
DIABETES TECHNOLOGY & THERAPEUTICS - 2025 -
Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and
Diabetes
Connie M. Rhee, Roma Y. Gianchandani, David Kerr, Athena Philis-Tsimikas, Csaba P. Kovesdy, Robert C. Stanton, Andjela T. Drincic, Rodolfo J. Galindo, Kamyar Kalantar-Zadeh, Joshua J. Neumiller, Ian H. de Boer, Marcus Lind, Sun H. Kim, Alessandra T. Ayers, Cindy N. Ho, Rachel E. Aaron, Tiffany Tian, David C. Klonoff
Journal of Diabetes Science and Technology - 2025 -
Insulin requirement trajectories during COVID-19 versus non-COVID-19 critical illness-A retrospective cohort
study
Navid Soltani, Henrike Habel, Anca Balintescu, Marcus Lind, Jonathan Grip, Ragnar Thobaben, David Nelson, Johan Martensson
ACTA ANAESTHESIOLOGICA SCANDINAVICA - 2025 -
Inhibition of leukotrienes and their potential role in type 1 diabetes pathogenesis: implications for montelukast as a therapeutic agent: a case
report
Pavel Jamal Fatulla, Ingela Strom, Christine Lingblom, Marcus Lind
FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE - 2024 -
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose
Monitors
David C. Klonoff, Guido Freckmann, Stefan Pleus, Boris P. Kovatchev, David Kerr, Chui Tse, Chengdong Li, Michael S.D. Agus, Kathleen Dungan, Barbora Voglová Hagerf, Jan S. Krouwer, Wei An Lee, Shivani Misra, Sang Youl Rhee, Ashutosh Sabharwal, Jane Jeffrie Seley, Viral N. Shah, Nam K. Tran, Kayo Waki, Chris Worth, Tiffany Tian, Rachel E. Aaron, Keetan Rutledge, Cindy N. Ho, Alessandra T. Ayers, Amanda Adler, David T. Ahn, Halis Kaan Aktürk, Mohammed E. Al-Sofiani, Timothy S. Bailey, Matt Baker, Lia Bally, Raveendhara R. Bannuru, Elizabeth M. Bauer, Yong Mong Bee, Julia E. Blanchette, Eda Cengiz, James Geoffrey Chase, Kong Y. Chen, Daniel Cherñavvsky, Mark Clements, Gerard L. Cote, Ketan K. Dhatariya, Andjela Drincic, Niels Ejskjaer, Juan Espinoza, Chiara Fabris, G. Alexander Fleming, Monica A.L. Gabbay, Rodolfo J. Galindo, Ana María Gómez-Medina, Lutz Heinemann, Norbert Hermanns, Thanh Hoang, Sufyan Hussain, Peter G. Jacobs, Johan Jendle, Shashank R. Joshi, Suneil K. Koliwad, Rayhan A. Lal, Lawrence A. Leiter, Marcus Lind, Julia K. Mader, Alberto Maran, Umesh Masharani, Nestoras Mathioudakis, Michael McShane, Chhavi Mehta, Sun Joon Moon, James H. Nichols, David N. O’Neal, Francisco J. Pasquel, Anne L. Peters, Andreas Pfützner, Rodica Pop-Busui, Pratistha Ranjitkar, Connie M. Rhee, David B. Sacks, Signe Schmidt, Simon M. Schwaighofer, Bin Sheng, Gregg D. Simonson, Koji Sode, Elias K. Spanakis, Nicole L. Spartano, Guillermo E. Umpierrez, Maryam Vareth, Hubert W. Vesper, Jing Wang, Eugene Wright, Alan H.B. Wu, Sewagegn Yeshiwas, Mihail Zilbermint, Michael A. Kohn
Journal of Diabetes Science and Technology - 2024 -
Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin
Glargine
Donald C. Simonson, Marcia A. Testa, Ella Ekholm, Maxwell Su, Tina Vilsboll, Serge A. Jabbour, Marcus Lind
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM - 2024 -
Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD
8)
T. Nyström, E. Schwarz, Sofia Dahlqvist, M. Wijkman, M. Ekelund, H. Holmer, J. Bolinder, J. Hellman, Henrik Imberg, I. B. Hirsch, Marcus Lind
Journal of Diabetes Science and Technology - 2024 -
Prevalence and risk factors for diabetic retinopathy at diagnosis of type 2 diabetes: an observational study of 77 681 patients from the Swedish National Diabetes
Registry
Sheyda Sofizadeh, Katarina Eeg-Olofsson, Marcus Lind
BMJ OPEN DIABETES RESEARCH & CARE - 2024 -
Performance of Subcutaneous Continuous Glucose Monitoring in Adult Critically Ill Patients Receiving Vasopressor
Therapy
Ola Friman, Navid Soltani, Marcus Lind, Pia Zetterqvist, Anca Balintescu, Anders Perner, Anders Oldner, Olav Rooyackers, Johan Martensson
DIABETES TECHNOLOGY & THERAPEUTICS - 2024 -
Trends in Survival After First Myocardial Infarction in People With
Diabetes
Linn Glynn, Marcus Lind, Tomas Andersson, Bjoern Eliasson, Robin Hofmann, Thomas Nystroem
JOURNAL OF THE AMERICAN HEART ASSOCIATION - 2024 -
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER
trials
Sofia Sterner Isaksson, Henrik Imberg, Irl B. Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Wijkman, Jan Bolinder, Thomas Nystrom, Helene Holmer, Sara Hallström, Arndis Olafsdottir, Sofia Pekkari, William Polonsky, Marcus Lind
DIABETOLOGIA - 2024 -
Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1
Diabetes
Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, Sara Hallström, Johan Jendle, Bengt-Olov Tengmark, Anna Folino, Ekstrom Marie, Marcus Lind
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY - 2024 -
The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover
trial
Sofia Sterner Isaksson, Arndis Olafsdottir, Simon Ivarsson, Henrik Imberg, Eva Toft, Sara Hallström, Ulf Rosenqvist, Marie Ekstrom, Marcus Lind
LANCET REGIONAL HEALTH-EUROPE - 2024 -
An "All-Data-on-Hand" Deep Learning Model to Predict Hospitalization for Diabetic Ketoacidosis in Youth With Type 1 Diabetes: Development and Validation
Study
David D. Williams, Diana Ferro, Colin Mullaney, Lydia Skrabonja, Mitchell S. Barnes, Susana R. Patton, Brent Lockee, Erin M. Tallon, Craig A. Vandervelden, Cintya Schweisberger, Sanjeev Mehta, Ryan McDonough, Marcus Lind, Leonard D'Avolio, Mark A. Clements
JMIR Diabetes - 2023 -
Evaluating a systematic intensive therapy using continuous glucose monitoring and intermittent scanning glucose monitoring in clinical diabetes care: a protocol for a multi-center randomized clinical
trial
Arndís F. Ólafsdóttir, Marcus Lind
Frontiers in Clinical Diabetes and Healthcare - 2023 -
Mortality in Patients With Primary Aldosteronism: A Swedish Nationwide
Study.
Eleftheria Gkaniatsa, Tatiana Zverkova Sandström, Annika Rosengren, Penelope Trimpou, Daniel S Olsson, Marcus Lind, Andreas Muth, Gudmundur Johannsson, Oskar Ragnarsson
Hypertension (Dallas, Tex. : 1979) - 2023 -
Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database
Study
Marcus Lind, S. B. Catrina, N. R. Ekberg, S. Gerward, T. Halasa, J. Hellman, D. Hess, M. Londahl, V. Qvist, J. Bolinder
Diabetes Therapy - 2023 -
Investigating immune profile by CyTOF in individuals with long-standing type 1
diabetes
Helen Larsson, Sofie Albinsson, Marcus Lind, Hardis Rabe, Christine Lingblom
SCIENTIFIC REPORTS - 2023 -
Design of a randomized cross-over study evaluating effects of carbohydrate intake on glycemic control in persons with type 1
diabetes
Sofia Sterner Isaksson, Arndís F. Ólafsdóttir, Marcus Lind
Frontiers in Nutrition - 2023 -
Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using Cerner Real-World Data &
TRADE
E. M. Tallon, M. P. Gallagher, V. S. Staggs, D. Ferro, D. B. Murthy, O. Ebekozien, M. N. Kosiborod, Marcus Lind, C. Manrique-Acevedo, C. R. Shyu, M. A. Clements
Bmj Open - 2023 -
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in
Sweden.
Jon Edqvist, Christina Lundberg, Karin Andréasson , Lena Björck, Pigi Dikaiou, Johnny Ludvigsson, Marcus Lind, Martin Adiels, Annika Rosengren
Diabetes care - 2023 -
Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the
UK
A. Gonzalez Perez, D. Vizcaya, M. E. Sáez, Marcus Lind, L. A. Garcia Rodriguez
BMJ open diabetes research & care - 2023 -
Glycaemic control and sepsis risk in adults with type 1
diabetes
A. Balintescu, Marcus Lind, M. A. Franko, A. Oldner, M. Cronhjort, B. Eliasson, C. Svensen, J. Martensson
Diabetes Obesity & Metabolism - 2023 -
Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled
Trial
R. Gabriel, N. Boukichou-Abdelkader, A. Gilis-Januszewska, K. Makrilakis, R. Gomez-Huelgas, Z. Kamenov, B. Paulweber, I. Satman, P. Djordjevic, A. Alkandari, A. Mitrakou, N. Lalic, J. Egido, S. Mas-Fontao, J. H. Calvet, J. C. Pastor, J. Lindstrom, Marcus Lind, T. Acosta, L. Silva, J. Tuomilehto
Journal of Clinical Medicine - 2023 -
Glycemic control and outcome after carotid intervention in patients with T2D: A Swedish nationwide cohort
study
A. Zabala, A. Gottsaeter, Marcus Lind, Björn Eliasson, R. Bertilsson, J. Ekelund, M. Jonsson, T. Nystroem
Diabetes & Vascular Disease Research - 2023 -
Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational
study
W. Linn, M. Persson, B. Rathsman, J. Ludvigsson, Marcus Lind, M. A. Franko, T. Nystrom
Cardiovascular Diabetology - 2023 -
Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study
protocol
J. Ludvigsson, L. Eriksson, C. Nowak, P. F. Teixeira, M. Widman, A. Lindqvist, R. Casas, Marcus Lind, U. Hannelius
Bmj Open - 2022 -
Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney
disease
Arndis Olafsdottir, M. Andelin, Aso Saeed, S. Sofizadeh, H. Hamoodi, Per-Anders Jansson, Marcus Lind
World Journal of Clinical Cases - 2022 -
Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2
Diabetes
A. Balintescu, Marcus Lind, M. A. Franko, A. Oldner, M. Cronhjort, Ann-Marie Svensson, Björn Eliasson, J. Mårtensson
Diabetes Care - 2022 -
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician
Ratings
D. C. Klonoff, J. Wang, D. Rodbard, M. A. Kohn, C. Li, D. Liepmann, D. Kerr, D. Ahn, A. L. Peters, G. E. Umpierrez, J. J. Seley, N. Y. Xu, K. T. Nguyen, G. Simonson, M. S. D. Agus, M. E. Al-Sofiani, G. Armaiz-Pena, T. S. Bailey, A. Basu, T. Battelino, S. Y. Bekele, P. Y. Benhamou, B. W. Bequette, T. Blevins, M. D. Breton, J. R. Castle, J. G. Chase, K. Y. Chen, P. Choudhary, M. A. Clements, K. L. Close, C. B. Cook, T. Danne, III Doyle, A. Drincic, K. M. Dungan, S. V. Edelman, N. Ejskjaer, J. C. Espinoza, G. A. Fleming, G. P. Forlenza, G. Freckmann, R. J. Galindo, A. M. Gomez, H. A. Gutow, L. Heinemann, I. B. Hirsch, T. D. Hoang, R. Hovorka, J. H. Jendle, L. Ji, S. R. Joshi, M. Joubert, S. K. Koliwad, R. A. Lal, M. C. Lansang, W. A. Lee, L. Leelarathna, L. A. Leiter, Marcus Lind, M. L. Litchman, J. K. Mader, K. M. Mahoney, B. Mankovsky, U. Masharani, N. N. Mathioudakis, A. Mayorov, J. Messler, J. D. Miller, V. Mohan, J. H. Nichols, K. Nørgaard, D. N. O’Neal, F. J. Pasquel, A. Philis-Tsimikas, T. Pieber, M. Phillip, W. H. Polonsky, R. Pop-Busui, G. Rayman, E. J. Rhee, S. J. Russell, V. N. Shah, J. L. Sherr, K. Sode, E. K. Spanakis, D. J. Wake, K. Waki, A. Wallia, M. E. Weinberg, H. Wolpert, E. E. Wright, M. Zilbermint, B. Kovatchev
Journal of Diabetes Science and Technology - 2022 -
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin
injections
Klara Westman, Henrik Imberg, M. O. Wijkman, I. B. Hirsch, J. Tuomilehto, Sofia Dahlqvist, Marcus Lind
Journal of Diabetes and its Complications - 2022 -
Body mass index in adolescence, risk of type 2 diabetes and associated complications: A nationwide cohort study of
men
Karin Andréasson , Jon Edqvist, Martin Adiels, Lena Björck, Martin Lindgren, S. Naveed, Marcus Lind, Maria A I Åberg, Annika Rosengren
EClinicalMedicine - 2022 -
Intralymphatic GAD-Alum (Diamyd (R)) Improves Glycemic Control in Type 1 Diabetes With HLA
DR3-DQ2
C. Nowak, Marcus Lind, Z. Sumnik, T. Pelikanova, L. N. Chavez, E. Lundberg, I. Rica, M. A. Martinez-Brocca, M. S. R. de Adana, J. Wahlberg, R. Hanas, C. Hernandez, M. Clemente-Leon, A. Gomez-Gila, M. F. Lozano, T. Sas, S. Pruhova, F. Dietrich, S. P. Marin, U. Hannelius, R. Casas, J. Ludvigsson
Journal of Clinical Endocrinology & Metabolism - 2022 -
Risk factors for nephropathy in persons with type 1 diabetes: a population-based
study
Shilan Seyed Ahmadi, Aldina Pivodic, A. M. Svensson, Hans Wedel, B. Rathsman, T. Nystrom, J. Ludvigsson, Marcus Lind
Acta Diabetologica - 2022 -
Risk factors, mortality trends and cardiovasuclar diseases in people with Type 1 diabetes and controls: A Swedish observational cohort
study
Sara Hallström, M. O. Wijkman, J. Ludvigsson, P. Ekman, M. A. Pfeffer, Hans Wedel, Annika Rosengren, Marcus Lind
Lancet Regional Health-Europe - 2022 -
LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort
study
B. Rathsman, J. Haas, M. Persson, J. Ludvigsson, Ann-Marie Svensson, Marcus Lind, M. A. Franko, T. Nystrom
Journal of Internal Medicine - 2021 -
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial
(GOLD-5)
Arndis Olafsdottir, J. Bolinder, T. Heise, W. Polonsky, M. Ekelund, M. Wijkman, Aldina Pivodic, Elsa Ahlén, E. Schwarcz, T. Nystrom, J. Hellman, I. B. Hirsch, Marcus Lind
Diabetes Obesity & Metabolism - 2021 -
Renal Complications and Duration of Diabetes: An International Comparison in Persons with Type 1
Diabetes
Mary Dena, Ann-Marie Svensson, Katarina Eeg-Olofsson, L. Young, A. Carlson, K. Miller, J. Grimsmann, R. Welp, J. K. Mader, D. M. Maahs, R. W. Holl, Marcus Lind
Diabetes Therapy - 2021 -
Evaluation of Reference Metrics for Continuous Glucose Monitoring in Persons Without Diabetes and
Prediabetes
Sheyda Sofizadeh, A. Pehrsson, Arndis Olafsdottir, Marcus Lind
Journal of Diabetes Science and Technology - 2021 -
Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS
88
Marcus Lind, Henrik Imberg, Ruth L. Coleman, Olle Nerman, Rury R. Holman
Diabetes Care - 2021 -
Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at
onset
Jon Edqvist, Araz Rawshani, Aidin Rawshani, Martin Adiels, S. Franzén, Lena Björck, A. M. Svensson, Marcus Lind, N. Sattar, Annika Rosengren
BMJ Open Diabetes Research and Care - 2021 -
Variables associated with insulin production in persons with type 2 diabetes treated with multiple daily insulin
injections
Klara Westman, Henrik Imberg, H. Albrektsson, I. B. Hirsch, J. Tuomilehto, Sofia Dahlqvist, Marcus Lind
Primary Care Diabetes - 2021 -
Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort
study.
Aidin Rawshani, Elin Allansson Kjölhede, Araz Rawshani, Naveed Sattar, Katarina Eeg-Olofsson, Martin Adiels, Johnny Ludvigsson, Marcus Lind, Magnus Gisslén, Eva Hagberg, Georg Lappas, Björn Eliasson, Annika Rosengren
The Lancet regional health. Europe - 2021 -
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With
MDI
Marcus Lind, Arndis Olafsdottir, I. B. Hirsch, J. Bolinder, Sofia Dahlqvist, Aldina Pivodic, J. Hellman, M. Wijkman, E. Schwarcz, H. Albrektsson, T. Heise, W. Polonsky
Diabetes Care - 2021 -
Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes
Registry
Sara Hallström, Ann-Marie Svensson, Aldina Pivodic, Arndis Olafsdottir, M. Londahl, Hans Wedel, Marcus Lind
Diabetologia - 2021 -
Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention: a Swedish nationwide propensity score matched cohort
study
A. Zabala, A. Gottsater, Marcus Lind, Ann-Marie Svensson, Björn Eliasson, R. Bertilsson, J. Ekelund, T. Nystrom, M. Jonsson
Cardiovascular Diabetology - 2021
More publications
We have limited the number of publications on this page. Visit GUP (The Publication Database for Gothenburg University) to find more publications.